Robert J. Decker - 15 Mar 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Signature
Raavi K. Deol, as attorney-in-fact for Robert J. Decker
Issuer symbol
JNJ
Transactions as of
15 Mar 2022
Net transactions value
-$514,830
Form type
4
Filing time
17 Mar 2022, 16:30:52 UTC
Previous filing
17 Feb 2022
Next filing
31 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $362,700 +5,000 +32% $72.54 20,473 15 Mar 2022 Direct
transaction JNJ Common Stock Sale $43,876 -250 -1.2% $175.51 20,223 15 Mar 2022 Direct
transaction JNJ Common Stock Sale $351,012 -2,000 -9.9% $175.51 18,223 15 Mar 2022 Direct
transaction JNJ Common Stock Sale $482,642 -2,750 -15% $175.51 15,473 15 Mar 2022 Direct
holding JNJ Common Stock 562 15 Mar 2022 By 401k F1
holding JNJ Common Stock 134 15 Mar 2022 By ESOP F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -5,000 -37% $0.000000 8,462 15 Mar 2022 Common Stock 5,000 $72.54 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2022).
F2 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2022).